Vascular Biogenics Ltd

NASDAQ:VBLT   3:59:54 PM EDT
2.18
+0.12 (+5.58%)
Earnings Announcements

VBL Therapeutics Reports Third Quarter 2021 Financial Results

Published: 11/15/2021 12:57 GMT
Vascular Biogenics Ltd (VBLT) - Vbl Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update.
Q3 Revenue $200,000.
Qtrly Loss of $0.09 per Basic Share.
Q3 Earnings per Share View $-0.11 -- Refinitiv Ibes Data (analyst estimates).
Q3 Revenue View $150000.00 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0.2 Million
Adjusted EPS is expected to be -$0.09

Next Quarter Revenue Guidance is expected to be $0.2 Million
Next Quarter EPS Guidance is expected to be -$0.09

More details on our Analysts Page.